Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 359

1.

A bupropion smoking cessation clinical trial for cancer patients.

Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.

Cancer Causes Control. 2010 Jun;21(6):811-20. doi: 10.1007/s10552-010-9507-8. Epub 2010 Jan 20.

PMID:
20087643
[PubMed - indexed for MEDLINE]
2.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
[PubMed - indexed for MEDLINE]
3.

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group.

JAMA. 2006 Jul 5;296(1):47-55.

PMID:
16820546
[PubMed - indexed for MEDLINE]
4.

Outcomes from an outpatient smoking-cessation clinic.

Roth MT, Andrus MR, Westman EC.

Pharmacotherapy. 2005 Feb;25(2):279-88.

PMID:
15767242
[PubMed - indexed for MEDLINE]
5.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
[PubMed - indexed for MEDLINE]
6.

Bupropion: a review of its use in the management of smoking cessation.

Holm KJ, Spencer CM.

Drugs. 2000 Apr;59(4):1007-24. Review.

PMID:
10804045
[PubMed - indexed for MEDLINE]
7.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
[PubMed - indexed for MEDLINE]
8.

A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.

Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M.

J Clin Psychopharmacol. 2008 Dec;28(6):660-6. doi: 10.1097/JCP.0b013e31818ad7d6.

PMID:
19011435
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB.

N Engl J Med. 1999 Mar 4;340(9):685-91.

PMID:
10053177
[PubMed - indexed for MEDLINE]
Free Article
10.

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.

Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G.

Addiction. 2004 Sep;99(9):1206-18.

PMID:
15317642
[PubMed - indexed for MEDLINE]
11.

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI.

Biol Psychiatry. 2008 Jun 1;63(11):1092-6. Epub 2007 Dec 21.

PMID:
18096137
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group.

JAMA. 2006 Jul 5;296(1):56-63. Erratum in: JAMA. 2006 Sep 20;296(11):1355.

PMID:
16820547
[PubMed - indexed for MEDLINE]
13.

Bupropion for smoking cessation: a randomized trial.

Simon JA, Duncan C, Carmody TP, Hudes ES.

Arch Intern Med. 2004 Sep 13;164(16):1797-803.

PMID:
15364675
[PubMed - indexed for MEDLINE]
14.

A comparison of sustained-release bupropion and placebo for smoking cessation.

Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM.

N Engl J Med. 1997 Oct 23;337(17):1195-202.

PMID:
9337378
[PubMed - indexed for MEDLINE]
Free Article
15.

Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.

Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, Berrettini W.

Neuropsychopharmacology. 2006 Jan;31(1):231-42.

PMID:
16123753
[PubMed - indexed for MEDLINE]
Free Article
16.

Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.

Shiffman S.

Clin Ther. 2008 Aug;30(8):1461-75. doi: 10.1016/j.clinthera.2008.07.019.

PMID:
18803988
[PubMed - indexed for MEDLINE]
17.

A placebo controlled trial of bupropion for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR.

Biol Psychiatry. 2002 Jul 1;52(1):53-61.

PMID:
12079730
[PubMed - indexed for MEDLINE]
18.
19.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD007253. doi: 10.1002/14651858.CD007253.pub3. Review.

PMID:
23450574
[PubMed - indexed for MEDLINE]
20.

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

T√łnnesen P, Tonstad S, Hjalmarson A, Lebargy F, Van Spiegel PI, Hider A, Sweet R, Townsend J.

J Intern Med. 2003 Aug;254(2):184-92.

PMID:
12859700
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk